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Genetic analyses of dwar®ng phenotypes resulting from targeted mutagenesis of the genes encoding the insulin-like growth
factors (IGF-I and IGF-II) and their cognate type 1 IGF receptor (IGF1R) have demonstrated that this signaling system is
a major determinant of mouse embryonic growth. Of the two IGF ligands, IGF-I interacts exclusively with IGF1R, whereas
IGF-II recognizes an additional receptor (XR), because the growth retardation of embryos lacking both IGR1R and IGF-II
(30% of normal birthweight) is more severe than that manifested in either class of single Igf1r or Igf2 null mutants (45
and 60% of normal, respectively). To determine whether XR is the insulin receptor (IR), we examined embryos nullizygous
for both Igf1r and Insr. While the growth of embryos lacking solely IR is affected very mildly and only at the end of
gestation, concomitant absence of IGF1R results in a severe growth-de®ciency phenotype (30% of normal size at birth)
that is ®rst detected at Embryonic Day 13.5 and is also characterized by transient edema, curly tail, generalized organ
hypoplasia, including the muscles, developmental delays in ossi®cation, and thin epidermis. The Igf1r/Insr double nullizy-
gotes are phenotypically indistinguishable from double mutants lacking IGF1R and IGF-II and from other double and triple
mutants in which all of the IGF ligand/receptor interactions have been eliminated. Therefore, these results provide genetic
evidence that the growth-promoting function of IGF-II during mouse embryogenesis is mediated in part by signaling
through the insulin receptor. q 1997 Academic Press
INTRODUCTION ion-independent mannose 6-phosphate receptor that is in-
volved in the traf®cking of lysosomal enzymes also acts as
The insulin-like growth factors, IGF-I and IGF-II, are mi- the type 2 IGF receptor (IGF2R) serving the turnover of
togenic polypeptides with a structural similarity to proinsu- excess IGF-II by receptor-mediated endocytosis (reviewed
lin, which are produced by many tissues and function in an by Nissley et al., 1991; Kornfeld, 1992; Ludwig et al., 1995).
autocrine/paracrine fashion, although they may also act as Previously, we disrupted the mouse genes encoding the
classical hormones, since they circulate in the plasma in IGF ligands and receptors by targeting and studied the phe-
association with binding proteins (reviewed by Jones and notypic consequences of the null mutations alone or in vari-
Clemmons, 1995). The signaling of both of these ligands is ous combinations (DeChiara et al., 1990; Liu et al., 1993;
mediated by the type 1 IGF receptor (IGF1R), a heterote- Baker et al., 1993; Ludwig et al., 1996). The results of these
trameric (a2b2) transmembrane glycoprotein that resembles analyses, summarized below and in Fig. 1, established the
the insulin receptor, and possesses extracellular ligand- in vivo relationships in ligand/receptor interactions and re-
binding and intracellular tyrosine kinase domains (reviewed vealed the growth-promoting developmental roles of the
by De Meyts et al., 1994; LeRoith et al., 1995; Rubin and IGFs. Moreover, genetic evidence was obtained indicating
Baserga, 1995). In mammals, the structurally unrelated cat- that an additional unknown signaling receptor exists, which
mediates in part IGF-II action during embryogenesis.
Because the maternal Igf2 allele is normally silent, due1 To whom correspondence should be addressed at Department of
to parental imprinting (reviewed by Efstratiadis, 1994), het-Genetics and Development, Columbia University, 701 West 168th
erozygous progeny carrying a paternally derived mutatedStreet, New York, NY 10032. Fax: (212) 923-2090. E-mail: arg@
cuccfa.ccc.columbia.edu. Igf2 gene [Igf2(//p0) mutants] are phenotypically indistin-
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guishable from Igf2 nullizygous mice (DeChiara et al., cili et al., 1996; Joshi et al., 1996). However, these mutants
survive postnatally only for a few days and then die of dia-1991). The mutants of both of these classes are invariably
viable dwarfs with 60% of normal birthweight (Fig. 1C). In betic ketoacidosis.
In an attempt to determine the identity of XR and expandcontrast, the survival of nullizygous mutants lacking IGF-
I, which also exhibit 60% of normal birthweight (Fig. 1B), our previous studies on the interactions of members of the
IGF family of growth effectors during mouse embryogene-depends on genetic background. The growth retardation of
Igf1r(0/0) nullizygotes, which die immediately after birth sis, we generated double mutants lacking both IGF1R and
IR and analyzed their phenotype.of respiratory failure, is more severe (45% of normal
birthweight; Fig. 1D). Double mutants lacking both IGF-I
and IGF1R do not differ in phenotype from Igf1r nullizy-
gotes, demonstrating that IGF-I interacts exclusively with MATERIALS AND METHODS
IGF1R in embryos (Fig. 1G). In contrast, double mutants
lacking both IGF-II and IGF1R (which are phenotypically Breeding of Mutant Mice
indistinguishable from double mutants lacking both the
The mice used in this study, which carried targeted mutationsIGF ligands) exhibit a birthweight that is 30% of normal
of the Igf1, Igf2, Igf1r, Igf2r, and Insr genes, have been described(cf. Figs. 1F and 1H); i.e., their growth retardation is more previously (DeChiara et al., 1990; Liu et al., 1993; Ludwig et al.,
severe than that manifested in either class of single mu- 1996; Accili et al., 1996).
tants. Therefore, IGF-II interacts with IGF1R and also with To generate Igf1r(0/0)/Insr(0/0) double mutants, we ®rst
an unknown receptor (XR), which is not IGF2R, as demon- crossed Igf1r(//0) and Insr(//0) heterozygotes and obtained F1
strated by the following results. Igf1r(//0)/Insr(//0) double heterozygotes (25% of the progeny),
which were then intercrossed (see Table 1A).Consistent with the imprinted status of the Igf2r gene
To generate Igf1(0/0)/Igf2(//p0) or Igf1(0/0)/Igf2(0/0) double(which is reciprocal to that of Igf2; Barlow et al., 1991),
mutants, which are phenotypically identical, we ®rst crossedthe phenotype of heterozygotes inheriting a mutated gene
Igf1(//0) heterozygous males with Igf2(0/0) homozygous femalesmaternally [Igf2r(//m0)] is indistinguishable from that of
and obtained Igf1(//0)/Igf2(//0) double heterozygotes (50% of thenullizygous mutants. Mice lacking IGF2R have increased
progeny), which were then intercrossed (see Table 1B).serum and tissue levels of IGF-II, exhibit overgrowth To generate Igf1r(0/0)/Igf2(//p0) double mutants, we had to
(140% of normal birthweight; Fig. 1E), and usually die rely on meiotic recombination events, since both of these genes
perinatally (Wang et al., 1994; Lau et al., 1994; Ludwig et reside on chromosome 7 at a distance of 39 cM apart (see Lyon et
al., 1996). This lethality is apparently caused by excess al., 1996). First, we crossed Igf2(0/0) homozygous females with
of IGF-II overstimulating IGF1R in the absence of IGF2R- Igf1r(//0) heterozygous males and obtained among the F1 progeny
Igf1r(//0)/Igf2(//0) double heterozygous males, which were thenmediated turnover, as evidenced by the fact that double
mated to Igf1r(//0) females, to produce among the F2 progeny themutants lacking both IGF2R and IGF-II (Fig. 1I) are fully
desired double mutants (see Table 1C).viable (Ludwig et al., 1996). Thus, when IGF-II is re-
To generate Igf1r(0/0)/Igf2r(//m0)/Igf2(//p0) triple mutants,moved, the absence of IGF2R has no detrimental conse-
we ®rst crossed Igf1r(//0) females with Igf2r(//0) males and ob-quences. Moreover, the involvement of IGF1R overstimu-
tained among the F1 progeny Igf1r(//0)/Igf2r(//0) double hetero-lation in the lethality of Igf2r mutants was demonstrated zygous females, which were then crossed with Igf1r(//0)/Igf2r
by the rescue of mutants lacking both IGF receptors (Fig. (//0)/Igf2(//0) triple heterozygous males (see Ludwig et al., 1996),
1J), although each individual mutation is lethal (Ludwig to produce among the F2 progeny the desired triple null mutants
et al., 1996). The normal embryonic development of these (see Table 1D).
Igf1r/Igf2r double mutants was attributed to signaling of To generate Igf1r(0/0)/Igf2r(//m0)/Insr(0/0) triple mutants,
we ®rst crossed Igf1r(//0)/Insr(//0) double heterozygous femalesIGF-II, being in excess, through XR, since triple mutants
with Igf1r(//0)/Igf2r(//0) males, and obtained triple heterozygouslacking IGF1R, IGF2R, and IGF-II are nonviable dwarfs
progeny [Igf1r(//0)/Igf2r(//0)/Insr(//0); 1/16], which were then(30% of normal size; Fig. 1K).
intercrossed (see Table 1E).Considering these data and also the cross-interaction
properties of the IGF and insulin systems, we asked whether
XR is the insulin receptor (IR). While the af®nity of insulin Genotyping
binding to IGF1R is 500±1000 times lower than that of the
For genotyping by Southern or PCR analysis, DNA was preparedIGFs, IGF-II binds to IR quite strongly with an af®nity that
as described (Hogan et al., 1994) from the yolk sac of e11.5±e18.5is only 10-fold lower than that of insulin (relative to insulin,
embryos. The probes used for Southern blotting, which can detectthe af®nity of IGF-I for IR is at least 50- to 100-fold lower;
both targeted and nontargeted alleles because of different sizes ofreviewed by Nissley et al., 1991; De Meyts et al., 1994).
restriction fragments, were: a 440-bp EcoRI±SpeI fragment locatedTherefore, given the genetically revealed speci®city of the
upstream of exon 4 of the Igf1 gene (Liu et al., 1993); a 460-bp
IGF-II/XR interaction in embryos, IR was considered as a BamHI±HincII fragment located downstream of exon 3 of the Igf1r
candidate for XR, although this hypothesis appeared to be gene (Liu et al., 1993); and a 700-bp BglII±HindIII fragment located
inconsistent with the observation that mutants nullizygous upstream of exon 1 of the Igf2r gene (Ludwig et al., 1996). For
for the Insr gene (encoding IR) exhibit normal embryonic detection of the Igf2 mutation by PCR ampli®cation, we used the
forward primer 5*-CTAGCTCAAAGCCTGCGTTTCTTT-3* cor-development and have reportedly normal birthweights (Ac-
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responding to intron sequence located 30 bp upstream from the A polypeptide (18 kDa) were measured by a scanning densitometer
(Molecular Dynamics). The derived values were corrected for smallsplice junction of the ®rst Igf2 coding exon and a neo reverse primer
5*-ATCCATCTTGTTCAATGGCCGATCCC-3*. PCR cycling was differences in the total amount of protein between loaded aliquots
and mutant to wild-type ratios were calculated.for 1 min at 947C, 1 min at 677C, and 1 min at 727C for 30 cycles.
The intact Insr allele was detected using the primer pair 5*-CTT-
GATGTGCACCCCATGTCT-3* (forward) and 5*-TCGGATGTT-
GATGATCAGGCT-3* (reverse) corresponding to the beginning Growth Analysis
and end of exon 4, while the targeted allele was detected with the
For staging of embryos, we considered noon of the day of vaginalsame forward Insr primer and a neo reverse primer 5*-ATATTG-
plug appearance as e0.5. For developmental analysis of growth, em-CTGAAGAGCTTGGCG-3*. PCR cycling was for 1 min at 947C,
bryos and their placentas were dissected and ®xed in 4% paraform-1 min at 607C, and 1 min at 727C for 30 cycles.
aldehyde. Prior to weight determination with a microbalance, the
specimens were patted dry with absorbent paper. For determination
of dry weights, freshly dissected embryos were weighed (wet weightHistological and Anatomical Analyses
determination) and then placed into tared tubes and dried by incu-
bation at 607C for 48 hr and 1007C for 24 hr, followed by a secondFor histopathology, embryos were ®xed overnight in 4% para-
weight measurement (see Babiarz et al., 1988).formaldehyde, 0.1 M phosphate buffer, pH 7.3, washed for 24 hr at
Regression analyses (plots of weight versus age) by application47C in 0.25 M sucrose, 0.2 M glycine, 0.1 M phosphate buffer, pH
of a Gompertz equation (see Laird et al., 1965) were performed by7.3, dehydrated, and embedded in paraf®n. Paraf®n blocks were
a curve-®tting computer program (SigmaPlot) using all of thesectioned at 6±8 mm and stained with hematoxylin and eosin.
weight data from each class of embryos. In the Gompertz functionFor skeletal analysis as described (Kaufman, 1992), embryos were
W  A exp[0b exp(0kt)], W and A are the weight at time t and theeviscerated, ®xed in 80% ethanol at room temperature for 1±2
asymptotic weight, respectively, while b and k are constants. Thisdays, dehydrated in 96% ethanol for 1 day, transferred to acetone
mathematical treatment takes into consideration that the speci®cfor 3 days, and then stained with alizarin red S and alcian blue 8GS
rate (1/W)1(dW/dt) of the exponential embryonic growth is notat 377C for 6 hr. The tissues were cleared with 1% KOH and the
constant, but declines exponentially. Speci®c growth rates (g) wereskeletons were stored in glycerol.
calculated using the equation g  0k ln (W/A).
Molecular Analyses
RESULTS
Northern analysis of poly(A)/ RNA was performed as described
(Sambrook et al., 1989), using as a hybridization probe a rat cDNA
Genetic Crossesfragment corresponding to the a subunit of IGF1R, which detected
an 11-kb Igf1r transcript (Werner et al., 1989) and an additional Previous results (Liu et al., 1993; Baker et al., 1993; Lud-
5.5-kb RNA species previously unreported in rodents. To provide wig et al., 1996) indicated that all of the in vivo ligand/
a loading control, the same blot was stripped and hybridized to a
receptor interactions of the IGF system had been accountedmouse cytoplasmic b-actin probe.
for as summarized in Figs. 1A±1K, except that the identityFor Western analysis, embryos were dissected, snap-frozen in
of XR remained unknown. Consistent with the interpreta-liquid nitrogen, and stored at 0707C until use. Total extracts were
tion of these relationships, three combinations of mutationsprepared by dounce homogenization in 50 mM Hepes, pH 7.6, 150
mM NaCl, 1 mM PMSF, 1% Triton X-100, 0.5 mg/ml leupeptin, result in identical growth-de®ciency phenotypes of e18.5
and 0.7 mg/ml pepstatin on ice. The insoluble material was pelleted embryos (and neonates), which exhibit about 30% of normal
and the supernatants were assayed for protein concentration (Brad- body weight (subsequently referred to as ``30% mutants,''
ford assay; Bio-Rad). Samples were analyzed by SDS±PAGE through for simplicity). Thus, when both ligands are absent (mutants
a 5% gel. The proteins were then electrotransferred overnight at lacking IGF-I and IGF-II; Fig. 1F), the phenotype is identical
47C to a nitrocellulose membrane in 0.01 M Caps, pH 11, 10% with that of embryos lacking both IGF-II and IGF1R (Fig.
methanol, and the blots were stained with Ponceau S to verify
1H) and also with the phenotype of triple mutants lackingequal loading and protein transfer. The membrane was blocked
both IGF receptors and IGF-II (Fig. 1K). In all three cases ofwith 5% dry nonfat milk in Tris-buffered saline, 0.05% Tween 20
these 30% mutants, all of the IGF ligand/receptor interac-for 1 hr at room temperature. After washing, the membrane was
tions are eliminated. We reasoned, therefore, that if theincubated at room temperature for 1 hr with 1 mg/ml of anti-
IGF1Rb polyclonal antibody (Santa Cruz Biotechnology) in unknown signaling receptor (XR) is the insulin receptor (IR;
blocking solution, followed by an incubation with horseradish per- Fig. 1L), ablation of both IGF1R and IR should also result
oxidase-conjugated goat anti-rabbit IgG antibody (Boehringer in the manifestation of a 30% mutant phenotype (Fig. 1N).
Mannheim) diluted 1:1000 in blocking solution (45 min at room To test the prediction of this hypothesis, we generated Igf1r/
temperature). After washing, the membrane was incubated for 1 Insr double nullizygous embryos and compared them with
min with ECL detection reagents (Enhanced Chemilluminescence; known 30% mutants.
Amersham) and then exposed to X-ray ®lm for 30 sec. A duplicate
Intercrossing of Igf1r(//0)/Insr(//0) double heterozy-(control) blot was prepared in parallel, except that samples were
gotes (see Materials and Methods) generated embryos be-analyzed by SDS±PAGE through a 15% gel and the membrane was
longing to four phenotypic classes obtained in the expectedincubated with anti-cyclophilin A polyclonal antibody (a gift from
9:3:3:1 Mendelian ratio: normal embryos; mutants lackingJ. Luban). The intensities of the bands corresponding to the IGF1R
proreceptor (135 kDa) and b-subunit (85 kDa) and the cyclophilin IGF1R; mutants lacking IR; and double mutants lacking
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excess (Fig. 1J). This was consistent with the 30% pheno-
type of triple mutants lacking IGF1R, IGF2R, and IGF-II
(Fig. 1K), demonstrating that, in the absence of IGF-II, XR
cannot rescue the embryos from growth de®ciency. In these
experiments, however, the IGF-II/XR interaction was exam-
ined only from the side of the ligand. To examine the inter-
action from the side of the receptor and test further the
hypothesis that XR is IR, we eliminated all three receptors
(IGF1R, IGF2R, and IR; see Materials and Methods, Fig. 1O,
and Table 1E), predicting that, if IR were absent, the excess
of IGF-II could not sustain normal embryonic growth. As
shown below, this prediction was also ful®lled and a 30%
mutant phenotype was again observed.
Phenotype of Igf1r/Insr Double Nullizygous
Embryos
Anatomical analysis. A few litters of progeny derived
from intercrosses of Igf1r/Insr double heterozygotes were
monitored at birth, but only two liveborn Igf1r/Insr double
nullizygotes were recovered, which exhibited 30% of nor-
mal size and died immediately of respiratory failure like
their Igf1r nullizygous littermates. As expected, Insr nulli-
zygous littermates failed to thrive, although they fed nor-
mally, and survived only for 2 days. Thus, to avoid perinatal
loss of mutants, we analyzed embryos between e11.5 and
FIG. 1. Summary of mutant phenotypes. Each panel shows the e18.5, considering that at the latter age the embryos are
interactions between IGF ligands (IGF-I  I; IGF-II  II) and recep- very similar to newborns.
tors (IGF1R  1R; IGF2R  2R) in wild-type and mutant mice. In addition to their smaller size, the double mutant em-
The interaction of IGF-II with a previously unknown receptor (XR), bryos lacking IGF1R and IR differed in external appearance
which is the insulin receptor (IR), as demonstrated in this study,
from wild-type littermates in two features. First, at e14.5,is also shown. Signaling interactions are represented with arrows,
but not earlier, the Igf1r/Insr double nullizygotes exhibitedwhereas a ``lollipop'' symbol denotes the IGF2R-mediated turnover
generalized subcutaneous edema that was most prominentof IGF-II. In the absence of turnover (E, J, and O), the amount of
on the dorsal side of the embryos and extended from theIGF-II increases (II, larger letters). The genotype of each single,
double, or triple mutant is indicated on top of each panel, while cervical region to the root of the tail and laterally to the
the corresponding phenotype (% of normal weight of e18.5 embryos proximal region of the limbs (Figs. 2A and 2B). In all exam-
or neonates; rounded numbers) is indicated at the bottom. Ligands ined cases, the accumulated ¯uid was clear and never hem-
and/or receptors that are absent in each case are crossed-out. orrhagic. From measurements of wet and dry weights, we
calculated that there was an increase in water content by
21% over the wild-type value at e14.5 (Table 2). The corre-
sponding increase in Igf1r nullizygotes did not exceed 7.5%,
while single Insr mutant embryos did not exhibit edema
(Table 2). In Igf1r/Insr double mutants, the edema persistedboth of these receptors (Table 1A). The normal embryos
were genotypically wild type or heterozygous for either one at e15.5 (Fig. 2C) and then declined variably in degree. Thus,
the edema had disappeared in ®ve of seven e16.5 doubleor for both of the Igf1r and Insr genes. In parallel, to provide
a basis for comparison, we generated known 30% mutants mutant embryos and in all three specimens examined at
e17.5. However, two of nine Igf1r/Insr double nullizygotes(lacking IGF-I and IGF-II; IGF-II and IGF1R; and IGF-II,
IGF1R, and IGF2R) from appropriate matings (see Materials recovered at e18.5 exhibited residual edema. Obvious histo-
logical abnormalities that could be associated with the de-and Methods and Table 1B±D). As described below, our
comparative analysis showed that the Igf1r/Insr double nul- velopment of edema were not detected and its cause re-
mains unknown. Several spontaneous or radiation-inducedlizygotes belong to the class of 30% mutants. Thus, our
prediction was ful®lled demonstrating that XR is indeed IR. mutations (see Biddle, 1990) and also some targeted muta-
tions (see e.g., Sucov et al., 1994; Kastner et al., 1994; Ta-To validate this conclusion, we provided additional ge-
netic evidence based on the following considerations. Pre- keuchi et al., 1995) are associated with edema during em-
bryogenesis. However, the subcutaneous edema observed inviously, the rescue of mutants lacking both IGF1R and
IGF2R, which are viable and exhibit normal birthweight, Igf1r/Insr double nullizygotes resembles only the edema
appearing spontaneously at e14 in about 56% of embryoswas attributed to overstimulation of XR by IGF-II being in
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TABLE 1
Breeding Data
Observed Expected
Number of relative relative Weight Weight
Phenotype embryos frequency frequency (g { SEM; e18.5) (% of normal)
(A) Intercrosses between Igf1r (//0)/Insr (//0) mice. Data: 764 genotyped e11.5-e18.5 embryos from 98 litters.
Normal 438 9.2 9.0 1.32 { 0.018 (n  73)
Lacking IGF1R 144 3.0 3.0 0.61 { 0.014 (n  23) 46.2
Lacking IR 143 3.0 3.0 1.19 { 0.032 (n  16) 90.2
Lacking IGF1R / IR 39 0.8 1.0 0.43 { 0.015 (n  9) 35.6
(B) Intercrosses between Igf1(//0)/Igf2(//0) mice. Data: 25 genotyped e18.5 embryos from 3 litters.
Normal 13 4.2 3.0 1.21 { 0.041
Lacking IGF-I 5 1.6 1.0 0.75 { 0.016 62.0
Lacking IGF-II 4 1.3 3.0 0.78 { 0.047 64.5
Lacking IGF-I / IGF-II 3 1.0 1.0 0.39 { 0.092 32.2
(C) Crosses between Igf1r (//0) females and Igf1r (//0)/Igf2(//0) males. Data: 43 genotyped e18.5 embryos from 6 litters.
Normal 16 7.4 7.0 1.30 { 0.034
Lacking IGF-II 17 7.9 8.0 0.79 { 0.018 60.8
Lacking IGF1R 5 2.3 3.0 0.64 { 0.029 49.2
Lacking IGF1R / IGF-II 5 2.3 2.0 0.44 { 0.012 33.8
(D) Crosses between Igf1r(//0)/Igf2r(//0) females and Igf1r(//0)/Igf2r(//0)/Igf2(//0) males. Data: 33 genotyped e18.5 embryos from 5 litters.
Normal 3 3.5 7.0 1.41 { 0.089
Lacking IGF1R 3 3.5 3.0 0.58 { 0.028 41.1
Lacking IGF2R 8 9.4 7.0 1.97 { 0.084 139.7
Lacking IGF-II 7 8.2 8.0 0.89 { 0.032 63.1
Lacking IGF1R / IGF2R 0 0 3.0
Lacking IGF1R / IGF-II 1 1.2 2.0 0.46 32.6
Lacking IGF2R / IGF-II 10 11.8 8.0 0.91 { 0.032 64.5
Lacking IGF1R / IGF2R / IGF-II 2 2.4 2.0 0.41 { 0.049 29.0
(E) Intercrosses between Igf1r (//0)/Igf2r (//0)/Insr (//0) mice. Data: 160 genotyped e18.5 embryos from 20 litters.
Normal 49 9.8 9.0 1.30 { 0.023
Lacking IGF1R 12 2.4 3.0 0.61 { 0.021 46.9
Lacking IGF2R 38 7.6 9.0 1.79 { 0.029 137.7
Lacking IR 19 3.8 3.0 1.09 { 0.019 83.8
Lacking IGF1R / IGF2R 17 3.4 3.0 1.21 { 0.036 93.1
Lacking IGF1R / IR 3 0.6 1.0 0.40 { 0.008 30.8
Lacking IGF2R / IR 17 3.4 3.0 1.64 { 0.049 126.2
Lacking IGF1R / IGF2R / IR 5 1.0 1.0 0.49 { 0.017 37.7
Note. Because the Igf2 and Igf2r genes are imprinted, and the Igf2 and Igf1r genes are linked on mouse chromosome 7, the expected
relative frequencies of phenotypes in (B±E) differ from Mendelian ratios (see also Liu et al., 1993; Ludwig et al., 1996). The percentage of
normal weight of mutants lacking IGF2R and IGF-II (64.5%; D) is signi®cantly lower than previously observed (74%; Ludwig et al., 1996),
for unknown reasons.
of the WB/ReJ strain, which is also nonhemorrhagic and this fully penetrant trait, which permitted identi®cation of
the double mutants by visual inspection prior to genotyp-transient (it disappears by e17) and extends from the head
caudally along the dorsal spine (Biddle, 1990). ing, is unclear. However, this tail ¯exion abnormality is not
associated with neural tube defects often observed in otherA second anatomical difference from wild type evident
in Igf1r/Insr double mutants from the earliest age examined mouse mutants with abnormal tails (see Copp et al., 1990;
Doolittle et al., 1996) and differs in morphology from the(e12.5) onward, was a dorsal curling of the tail by more than
907 relative to the longitudinal axis (Fig. 2D). The cause of kinky (``hairpin'') tail characterizing Igf2r mutants (Wang
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FIG. 2. Igf1r/Insr double nullizygous embryos at e14.5 (A and B), e15.5 (C), and e18.5 (D). The presence of subcutaneous edema, which
in the case of the embryo in (A) is extreme, is indicated with an arrowhead. The embryo in (D) is compared with other 30% e18.5 mutant
embryos lacking IGF-II and IGF1R (E), IGF-II, IGF1R and IGF2R (F), IGF-I and IGF-II (G), or IGF1R, IGF2R and IR (H). An arrow indicates
a tail ¯exion abnormality.
et al., 1994; Lau et al., 1994; Ludwig et al., 1996). Curling was disproportionately large in Igf1r and Igf1r/Insr nullizy-
gotes (11% of the body weight on average vs 6.5% in wild-of the tail was observed only in a fraction (36/138; 26%)
of Igf1r nullizygous embryos examined between e11.5 and type and Insr single mutant littermates) and appeared to
compress the small thoracic cavity.e18.5.
Autopsies at e18.5 revealed that, despite a generalized Histological analyses. While previous histopathological
analyses of Insr nullizygous embryos (Accili et al., 1996;hypoplasia observed in most of the internal organs, the liver
TABLE 2
Embryo Water Content
e13.5 e14.5
Water contenta Percentage increase Water content Percentage increase
Phenotype ({SEM) over normal Db ({SEM) over normal D
Normal 8.4 { 0.05 (22) 8.0 { 0.11 (31)
Lacking IR 8.5 { 0.08 (10) 1.2 0 8.1 { 0.19 (9) 1.2 0
Lacking IGF1R 8.7 { 0.29 (6) 3.6 0 8.6 { 0.16 (7) 7.5 /
Lacking IGF1R / IR 8.7 { 0.53 (2) 3.6 0 9.7 { 0.45 (4) 21.2 /
a Water content per unit dry weight  (wet weight 0 dry weight)/dry weight. Mean values { SEM were calculated from the number of
specimens shown in parentheses. In mice, as in all mammals, total body water decreases with embryonic age (see Altman and Dittmer,
1974).
b The presence (/) or absence (0) of a statistically signi®cant difference (D) is indicated (Student's t test; P  0.05).
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Joshi et al., 1996) did not reveal signi®cant differences from in Igf1r single mutants (cf. Figs. 4C and 4E), while a differ-
wild type, we expected that the development of bones, mus- ence in the histological appearance of the intercostal mus-
cles, and skin will be affected in Igf1r/Insr double mutants cles was not detected between these two groups (cf. Figs.
as in Igf1r single mutants (Liu et al., 1993), but more se- 4D and 4F).
verely. The skin of Igf1r and Igf1r/Insr mutant embryos is not
To ascertain the degree of bone development, we com- opaque as in wild-type or Insr nullizygous littermates, but
pared the skeletons of Insr, Igf1r, and Igf1r/Insr mutants quite translucent. It was previously shown that this appear-
and wild-type littermates at e16.5±e18.5, after staining ance of the skin in Igf1r mutants is due to a reduction of
with alcian blue and alizarin red (Figs. 3A±3L), using for the epidermis in thickness relative to wild type (cf. Figs.
simplicity a qualitative criterion and scoring for the ®rst 4O and 4P), because one of its layers (stratum spinosum)
appearance of ossi®cation centers, rather than determin- remains underdeveloped. Skin histology revealed that the
ing the degree to which ossi®cation has progressed. De- epidermis of Igf1r/Insr double nullizygotes was even thin-
spite some expected minor differences, due to develop- ner than in Igf1r single mutants (cf. Figs. 4P and 4Q).
mental variability between and within litters for embryos The Igf1r/Insr double mutants were then compared with
of the same genotype, examination of several specimens triple receptor mutants (lacking IGF1R, IGF2R, and IR)
of each class of embryos allowed us to reach the following and with the other 30% mutants (lacking IGF-I and IGF-
conclusions. II; IGF-II and IGF1R; and IGF-II, IGF1R, and IGF2R) at
In comparison to wild type, the Insr mutants exhibited a e18.5. These comparisons demonstrated that, within the
developmental delay of approximately 1 embryonic day in limits of developmental variability, the phenotypic fea-
the appearance of ossi®cation centers in the middle digits tures of all classes of these embryos, in terms of body
of the forelimbs and hindlimbs, while shorter delays were size (Table 1), dorsal tail ¯exion (cf. Figs. 2D and 2E±2H),
detected in the bodies of cervical and caudal vertebrae and delays in bone development (cf. Figs. 3L and 3M±3P; 3T
in the neural arches. Consistent with previous observations and 3U±3X), respiratory muscle hypoplasia (cf. Figs. 4E
(Liu et al., 1993), the ossi®cation centers of facial and cranial and 4G, 4I, 4K, 4M; 4F and 4H, 4J, 4L, 4N), and underdevel-
bones appeared after a 2-day delay in Igf1r mutants in com- opment of the skin (cf. Figs. 4Q and 4R±4U), were practi-
parison with wild-type embryos, except for the interparietal cally indistinguishable.
bone (delay of 4 embryonic days). The time lag was 1±2 Molecular analyses. Altogether, the described results
days for the bones of the trunk and extremities. In Igf1r/
provided strong genetic evidence that the previously un-
Insr double mutants, the developmental delays in the ap-
known IGF-II-speci®c receptor (XR) is IR. However, since
pearance of ossi®cation centers were prolonged further.
IGF-II interacts with both IGF1R and IR during embryonicThus, at e16.5, signs of ossi®cation were completely absent
development in the mouse, the absence of severe pheno-from the double mutants, while the Igf1r single mutants
typic manifestations from Insr single mutants remainedexhibited ossi®cation centers in several bones of the head,
puzzling. Thus, we hypothesized that IGF1R can potentiallythe body, and the extremities. Similarly, at e17.5, in con-
compensate for the lack of IR in Insr mutants. To test thistrast to the Igf1r mutants, the Igf1r/Insr double mutants
hypothesis, we ®rst examined by Northern analysiswere devoid of ossi®cation centers in the zygomatic bone,
whether the expression of Igf1r is upregulated in Insr mu-the tympanic ring, the body of the atlas, the caudal verte-
tants. Quantitation of the results from this analysis (Fig.brae, and the distal digits of the forelimbs and hindlimbs.
5A) showed that this is not the case; no difference in theAt e18.5, the double mutants lacked ossi®cation centers in
level of Igf1r mRNAs was detected between wild-type andthe bodies of the ®rst four thoracic vertebrae and in the
Insr mutant embryos at three ages examined (see legend toproximal digits of the forelimbs and hindlimbs, while the
Fig. 5). To examine whether a difference could exist at thecartilage at the lower region of the xiphoid process of the
protein level, we analyzed protein extracts from whole em-sternum (xiphisternum) remained bifurcated (delay of at
bryos by Western blotting using a polyclonal antibody thatleast 2 embryonic days; Fig. 3T).
recognizes the b-subunit of IGF1R and the IGF1R precursorOur histological analysis of muscle development in
(see Materials and Methods). Quantitation of reproducibleIgf1r/Insr mutants was focused on the diaphragm and the
results (see Fig. 5B) showed that, in comparison with theintercostal muscles, since a reduction in the number of
wild type, the level of IGF1R protein is increased approxi-myocytes in these respiratory muscles is one of the possi-
mately twofold in Insr mutants. Although the mechanismble explanations for the death of Igf1r and Igf1r/Igf2 mu-
involved in this increase is unknown, the results appear totant neonates, which exhibit generalized muscle hypopla-
be consistent with the postulated compensatory functionsia and are unable to breathe (Liu et al., 1993). As expected,
of IGF1R. It is notable, in this regard, that the patterns ofsevere hypoplasia of the diaphragm and the intercostal
expression of the Igf1r and Insr genes examined by in situmuscles was observed in Igf1r/Insr double nullizygotes in
hybridization in rat embryos are very similar, except thatcomparison with wild-type controls (cf. Figs. 4A and 4E;
the abundance of transcripts that are detected in virtually4B and 4F), while the Insr single mutants were unaffected
all tissues differs in liver and fat (high expression of Insr(not shown). The development of the diaphragm was also
more severely affected in Igf1r/Insr double mutants than and low expression of Igf1r; Bondy et al., 1994).
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FIG. 4. Histological comparison of the development of respiratory muscles and skin in e18.5 wild-type and mutant embryos indicated
on top of each column (abbreviations are as in Fig. 3). (A, C, E, G, I, K, M) diaphragm; (B, D, F, H, J, L, N) intercostal muscles; (O±U) skin
sections at the level of the heart, dorsal to the spinal cord (for details, see text).
Embryonic and Placental Growth cally identical during embryogenesis, except that a statisti-
cally signi®cant difference in average weights was detectedThe developmental increase of the embryo in size
at e18.5. Since an abrupt change in the putative compensa-(growth) is effected by proliferative events increasing the
tory role of IGF1R occurring at e18.5 appears to be unlikely,total cell number. The rate of this proliferation, which
the detected growth difference of Insr nullizygotes fromdetermines the growth process, is re¯ected in the progres-
wild type can be attributed to lack of mediation of insulinsive increase of embryonic weight. Thus, growth curves
action commencing late in development (see Discussion).(plots of weight versus developmental age) provide an
As expected (see Baker et al., 1993), statistically signi®-overall growth index that can be used for comparisons
cant differences in weight between wild-type embryos andof relative growth rates between wild-type and mutant
mutants lacking IGF1R were detected at all times exam-embryos. However, because of developmental asynchrony
ined. A comparison between Igf1r single mutants and Igf1r/of embryos with the same genotype and gestational age
Insr nullizygotes showed that these two classes of embryoswithin and between litters, their weight values always
became statistically distinct in size at e13.5; double mu-vary within a range (see Fig. 6A). For this reason, to in-
tants were not recovered at e11.5, while the weight of acrease the accuracy of growth curves, we examined a large
unique double nullizygote obtained at e12.5 was within thenumber of litters and subjected the data to statistical and
range of values observed in Igf1r single mutant embryos.regression analyses (Figs. 6A and 6B).
However, in contrast to e13.5, a statistically signi®cant dif-A comparison between wild-type embryos and mutants
lacking IR showed that their growth processes were practi- ference in weights between Igf1r and Igf1r/Insr mutants was
FIG. 3. (A±L) Comparison of skeletons stained with alcian blue and alizarin red of wild-type (W) and mutant embryos lacking insulin
receptor (IR), IGF1R (1R), or both of these receptors (1R / IR) at the embryonic ages indicated on the left of each row. The ®rst appearance
of ossi®cation centers was determined from these and other specimens (for details, see text). The skeleton of an e18.5 double mutant
lacking IGF1R and IR (L) is also compared with the skeletons of other 30% mutants of the same embryonic age lacking (M) IGF-I and
IGF-II (I / II); (N) IGF1R and IGF-II (1R / II); (O) IGF1R, IGF2R, and IGF-II (1R / 2R / II); and (P) IGF1R, IGF2R, and IR (1R / 2R / IR).
(Q±X) Magni®ed view of the xiphoid process of the embryos shown in (C, F, I, L) and (M±P), to demonstrate that the cartilaginous
xiphisternum remains bifurcated (arrowhead) in the double and triple mutants in (T±X).
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FIG. 5. (A) Northern analysis of poly(A)/ RNA from wild-type
(W) and Insr nullizygous (IR) embryos at e18.5. The membrane was
hybridized with an Igf1r probe and then stripped and rehybridized
with a b-actin probe (see Materials and Methods). The size of de-
tected Igf1r transcripts is indicated. Identical results (no difference
in the level of Igf1r transcripts between wild-type and Insr null
embryos) were obtained at e13.5 and e15.5 (not shown). (B) Western
analysis of total protein extracts from wild-type (W) and Insr nulli-
zygous (IR) embryos at e13.5 using a polyclonal antibody that de-
tects the IGF1R receptor precursor (135 kDa) and the b-subunit (85
kDa). A duplicate (control) blot processed in parallel was analyzed
with an antibody against cyclophilin A. The Insr nullizygous em-
FIG. 6. Embryonic growth kinetics. (A) Plot of weights of wild-typebryos were from different litters.
(W), Insr(0/0) (IR), Igf1r(0/0) (1R) and Igf1r(0/0)/Ir(0/0) (1R/IR) em-
bryos versus gestational age. The data are from 98 litters (764 geno-
typed embryos; Table 1A). In the plot, each symbol (dash) represents
a single embryo (many dashes are superimposed). For clear displaynot detected at e14.5 and e15.5, and became again evident
allowing comparisons, the same symbol is used for all classes of em-from e16.5 onward. We attribute this deviation at e14.5 and
bryos. Each data group corresponding to a particular embryonic day ise15.5 to retention of excess water in the double mutants
presented in the form of four columns centered around the cognate(edema) affecting the weight measurements at these ages.
time point (as in histograms). Statistical analysis using Student's t testNevertheless, regression analysis indicated that the growth
(P 0.05) showed a signi®cant difference in mean values between the
curves of Igf1r and Igf1r/Insr mutants were distinct from W and IR groups only at e18.5. (B) The growth curves represent the
e13.5 onward (Figs. 6B and 6C). The growth retardation ob- results of regression analyses of the data in (A) using the Gompertz
served in these two classes of mutants was directly corre- function (see Materials and Methods). With the exception of the e18.5
lated to decreased speci®c growth rates in comparison with time point, the curves for wild-type embryos and mutants lacking IR
are practically identical (for further details, see text). (C) The ratios ofthe wild-type (approximately 90 and 70% of normal in Igf1r
mutant to wild-type weights from e13.5 onward are shown for embryosand Igf1r/Insr mutants, respectively; Fig. 6D). As a result,
lacking IGF1R and IGF1R/ IR. These ratios were calculated from thethe relative weights of the embryos became about 45 (Igf1r)
values of the growth curves in (B). At e18.5, the weights of Igf1r singleand 30% (Igf1r/Insr) of normal at e18.5 (Fig. 6C).
mutants and Igf1r/Insr double mutants are close to the rounded valuesWhat are the relative contributions to growth of the IGF-
of 45 and 30% of normal (see Fig. 1), respectively. (D) The naturalII/IGF1R and IGF-II/IR interactions? To provide a rough es-
logarithm of the speci®c growth rate (g; see Materials and Methods)
timate, we calculated the respective fractions of embryonic for the embryos shown is plotted versus developmental age. Calcula-
weight resulting from these interactions, according to the tions from this analysis reveal that throughout the period of observa-
following considerations. The weight D of Igf1r/Insr double tion the speci®c growth rate of Igf1r single mutants and Igf1r/Insr
nullizygous mutants, in which all of the IGF interactions double mutants was 88 and 71% of that of wild-type embryos, respec-
tively. (E) The relative fractions of embryonic weight resulting fromhave been eliminated (see Fig. 1), is the result of growth by
the interactions of IGF-II with the IGF1R and IR receptors from e13.5mechanisms unrelated to the IGF system. Therefore, if W
onward were calculated from the values in (B). The weight of Igf1r/is the wild-type weight value, the weight resulting from
Insr double mutants, in which all IGF interactions are eliminated, isIGF action at each time point is the difference W0D, which
the result of growth by mechanisms unrelated to the IGF system.consists of three components: a, weight resulting from the
Thus, at each time point, the weight resulting from IGF action isIGF-I/IGF1R interaction; b, weight resulting from the IGF-
the remainder after subtraction of the 1R/IR weight value from the
II/IGF1R interaction; and c, weight resulting from the IGF- corresponding wild-type value (D and W, respectively), and consists
II/IR interaction, i.e., W 0 D  a / b / c (1) (see Figs. 1 and of three components: a, weight resulting from the IGF-I/IGF1R interac-
6E). If II and R are the weights of Igf2 and Igf1r mutants, tion; b, weight resulting from the IGF-I/IGF1R interaction; and c,
respectively, it follows that a  II 0 D (2) and c  R 0 D weight resulting from the IGF-II/IR interaction (i.e., W-D  a / b /
c). For further details, see text.(3). The value of b can then be calculated from Eq. [1]±
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have placentas of normal size (Baker et al., 1993). Con-
versely, excess of IGF-II in mutants lacking IGF2R results
in placental overgrowth (Ludwig et al., 1996). This increase
in placental size is also observed in Igf1r/Igf2r double mu-
tants, although the birthweights of mice are normal (Ludwig
et al., 1996). These results, in conjunction with the data
reported here, provide genetic evidence for the existence
of an unknown, placenta-speci®c receptor (XRp), which is
distinct from IGR1R and IR and mediates the IGF-II growth-
promoting role in this organ.
DISCUSSION
Functional Interplay of the IGF and Insulin
Systems
FIG. 7. Mean placental weights of a subset of the embryos in Fig.
We have presented conclusive genetic evidence demon-3A are plotted versus gestational age. As expected, the placenta
strating that the growth-promoting function of IGF-II dur-stops growing and actually loses weight toward the end of gestation
ing mouse embryogenesis is mediated via two evolution-(see McLaren, 1965). The width of the vertical bars represents 2
arily and structurally related receptors, IGF1R and IR. Com-SEM. Statistical analysis using Student's t test (P  0.05) did not
show signi®cant differences between wild-type controls and any of plementary evidence supporting this conclusion was
the mutants examined (lacking IR, IGF1R or both of these recep- provided by direct examination of the IGF-II/IR interaction
tors). Thus, only average values of all four classes of embryos are in derivatives of cultured R0 cells, a ®broblast-like cell line
shown in a single curve. The numbers of placental specimens originated from mutant embryos lacking IGF1R. It was
weighed at each time point are shown in parentheses. shown that R0 cells overexpressing IR from a stably inte-
grated plasmid (R0/IR cells) are able to grow in serum-free
medium (SFM) supplemented solely with insulin or IGF-II,
but not with IGF-I (Morrione et al., 1997). Interestingly, at[3]. Although our current growth analysis (Fig. 6A) did not
involve Igf2 mutants, it was still possible to determine a any physiological concentration tested, IGF-II stimulated
proliferation of R0/IR cells at least twofold better than insu-and b values, because calculations from previous data (Baker
et al., 1993) showed that the ratios a/(a / b / c) and b/(a / lin. Moreover, when a second plasmid expressing Igf2 was
introduced into R0/IR cells, secretion of IGF-II into the me-b/ c) are about 0.45 and 0.55, respectively, which indicated
that the IGF-I/IGF1R and IGF-II/IGF1R interactions make dium exerted an autocrine effect, and the cells became able
to proliferate in SFM without growth factor supplementa-almost equal contributions to embryonic growth. Using
these ratios and applying Eqs. [1] and [3] to the data of the tion (Morrione et al., 1997).
Thus far, the generally accepted view was that underregression analysis (Fig. 6B), we determined the b and c
components and plotted the ratios b/(b / c) and c/(b / c) physiological conditions IR serves insulin signaling in-
volved in metabolic effects, whereas IGF1R serves IGF sig-(Fig. 6E). These calculations, re¯ecting the relative contri-
butions of the two IGF-II interactions with the receptors, naling involved in growth. Our results indicate, however,
that at least in mice the role of IR during most of the embry-revealed that the action of IGF-II via IGF1R predominates
throughout embryogenesis, but is not constant. Thus, at onic period is predominantly related to IGF-II signaling and
growth control, rather than to mediation of insulin func-e13.5, the effect of the IGF-II/IR interaction on embryonic
weight is small (less than 10% of the total IGF-II activity). tions. Nevertheless, insulin does appear to play a minor role
in growth, which cannot be compensated late in gestation,However, the secondary, IR-mediated action of IGF-II in-
creases with age progressively, although not linearly, be- as evidenced by the results of targeting of the genes encod-
ing IR or insulins (Ins2 and Ins1). In contrast to humanscoming about 40% of the total at e18.5.
In parallel with the study of embryonic growth kinetics, and most other vertebrate species, which possess a single
gene encoding insulin II, the genome of rats and mice con-we also recorded placental weights. Statistical analysis of
the data demonstrated no signi®cant differences in weights tains an additional nonallelic gene (a functional retroposon)
encoding insulin I (see Soares et al., 1985). While Ins2 orbetween wild-type and mutant placentas (Insr, Igf1r, and
Igf1r/Insr) at any developmental age between e11.5 and Ins1 single nullizygotes are viable and fertile, Ins2/Ins1 dou-
ble nullizygotes mimic after birth the phenotype of neo-e17.5 (a placental growth curve with averaged data is shown
in Fig. 7). This analysis complements our previous results, nates lacking IR and die of ketoacidosis within 48 hr (Duvil-
lieÂ et al., 1997). At e18, these double mutants exhibit mildwhich showed that placental growth is compromised only
in mutants lacking IGF-II (alone or in combination with growth retardation (80±85% of normal weight; DuvillieÂ et
al., 1997), which is comparable to the relative weight of 84±other mutations), while mutants lacking IGF-I or IGF1R
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90% of normal that we have observed for Insr nullizygotes lymphoblast cell lines derived from Efe pygmies, the steady-
state level of IGF1R mRNA was approximately 2±13% ofat e18.5 (Table 1A and E). It is likely that, in the absence
of insulin action, the reduced embryonic weights just prior the control value, while the levels of the INSR and GHR
(growth hormone receptor) mRNAs were normal. Moreover,to birth fall within a narrow range. Thus, despite pancreatic
agenesis resulting from the elimination of insulin promoter although the af®nity of IGF-I for IGF1R was unaffected, the
number of binding sites per cell was 5.5±22% of the controlfactor 1, the birthweight of Ipf1 nullizygous mice is report-
edly either indistinguishable from wild type (Of®eld et al., value (with the exception of 1/6 lines; 65%). Interestingly,
the cell lines from pygmies remained unresponsive to high1996) or at least 80% of normal (Jonsson et al., 1994, 1995).
It remains to be seen whether the birthweight of mice nulli- concentrations of IGF-I in clonal proliferation assays (Geff-
ner et al., 1995), and residual IGF1R molecules failed tozygous for the Pax4 gene, which lack mature insulin-pro-
ducing b-cells, is indeed normal as reported (Sosa-Pineda et become autophosphorylated by this stimulation, although
alterations in the IGF1R coding region were not detected byal., 1997) or close to the normal range.
Although involved in growth control, IR is apparently cDNA sequencing. Interestingly, however, these cell lines
responded and became growth-stimulated by IGF-II (D. W.unable to compensate for the growth-promoting functions
of IGF1R, unless there is excess of IGF-II. Thus, when IGF1R Golde, personal communication). On the basis of our obser-
vations, it can be hypothesized that this IGF-II action couldis absent, IGF-II (presumably in normal concentrations)
could continue to promote growth through IR, but this func- be mediated by IR.
In contrast to the apparently similar actions of the IGFs intion is inadequate, and cannot prevent the severe dwar®sm
that results from the lack of interactions between IGF1R human and mouse growth, the hormonal effects of insulin
exhibit a dramatic difference between the two species: ab-and its ligands. When both IGF1R and IGF2R are absent,
however, the concentration of IGF-II increases signi®cantly sence of insulin or lack of functional IR during human em-
bryonic development result in severe growth de®ciency thatbecause of the elimination of IGF2R-mediated degradation,
and overstimulation of IR by IGF-II compensates fully for is not observed in mice. IUGR of comparable severity due
to lack of insulin has been reported in cases of pancreaticthe growth requirements of the embryo, which attains nor-
mal size. The genetic evidence consistent with this view agenesis (Dourov and Buyl-Strouvens, 1969; MeÂhes et al.,
1976; ToÈpke and Menzel, 1976; Hill, 1978; Wright et al.,was derived by generating triple mutants to demonstrate
that both of the participants in the interaction, IR and ex- 1993; Voldsgaard et al., 1994), absence of b-cells or pancre-
atic islets (Dodge and Laurence 1977; Jonas et al., 1991;cess of IGF-II, are necessary for normal growth. Thus, al-
though double mutants lacking IGF1R and IGF2R are indis- Blum et al., 1993), or transient neonatal diabetes (reviewed
by FoÈ sel, 1995), a syndrome linked in familial cases to antinguishable from wild-type at birth, they become nonvia-
ble dwarfs with 30% of normal size when they carry a third unknown imprinted gene on chromosome 6q22-23 (Temple
et al., 1996). Interestingly, one case of pancreatic agenesismutation removing either IR or IGF-II. Accordingly, excess
of IGF-II in triple mutants is ineffective when IR is missing, (Wright et al., 1993) was attributed to a homozygous single-
base deletion in the human IPF1 gene causing a frame shiftand conversely IR is inert in the absence of IGF-II.
that resulted in the appearance of a downstream termina-
tion codon and truncation of the protein product (Stoffers
IGFs, Insulin, and Embryonic Growth in Humans et al., 1997).
and Mice Insulin inaction due to IR defects occurs in lepre-
chaunism, a genetic disorder resulting in death at infancy,The signi®cance of the IGF system not only for mouse,
but also for human fetal growth was documented by the which is characterized by severe IUGR, diminished muscle
and subcutaneous adipose tissue, and other manifestationsdescription of a 15-year-old patient carrying a homozygous
partial deletion (exons 4 and 5) of the IGF1 gene (Woods (see Taylor et al., 1992; Koller et al., 1995; Accili, 1995).
Although the leprechaun syndrome is genetically heteroge-et al., 1996). This mutation was manifested with severe
intrauterine growth retardation (IUGR) and postnatal neous, complete absence of IR function has been reported
in three cases of homozygous mutations resulting in trunca-growth failure, including delayed bone development. Al-
though the growth de®ciency of the IGF1 null patient was tion of the protein product (Krook et al., 1993; Psiachou et
al., 1993; Hone et al., 1995; Jospe et al., 1996) and in onerelatively more severe than that of mice lacking IGF-I, the
overall phenotypic features were strikingly similar, except case involving a homozygous deletion of the entire INSR
gene (Wertheimer et al., 1993). In leprechauns, insulin canthat the development of the reproductive system was appar-
ently unaffected (Woods et al., 1996), in contrast to the reach levels as high as 400-fold over normal (see Krook et
al., 1993), but the overall growth is impaired, and the pa-mutant mice (Baker et al., 1996).
Additional information relating the IGF system to human tients do not differ in birthweight from newborns with insu-
lin de®ciency. This indicates that, while IGF-II interactsgrowth was derived from studies with African pygmies. Al-
though the exact cause of low birthweight (Bailey, 1991) with IR in mice and possibly in humans, insulin does not
promote the growth of the whole organism via IGF1R.and short stature of pygmies continues to remain unknown,
decreased IGF1R expression and signaling were recently Therefore, as previously suggested (see e.g., Gluckman,
1995), insulin does not appear to be a major mitogen in theproposed as being involved (Hattori et al., 1996). In
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context of the developing fetus, in contrast to the IGFs, and 1969), is maintained at a low and almost constant level
(Thorell, 1970; Kaplan et al., 1972; Pronina and Sapronova,whatever growth-promoting effects it exerts can be predom-
inantly attributed to its metabolic actions. 1976; Economides et al., 1991). After the 25th week, how-
ever, insulin increases signi®cantly in concentration both
in the pancreas and the serum (Pronina and Sapronova,
Growth Retardation and Developmental Timing 1976; Economides et al., 1991), and apparently becomes in-
volved in growth at around this time onward. It is interest-Body size at birth is determined by the growth rate and
the duration of gestation. Thus, although the mouse embryo ing, in this regard, that ultrasound examinations in two
cases of IUGR due to pancreatic agenesis (Wright et al.,grows with a higher rate than the human embryo and
reaches, for example, a weight of 1 g three times faster (17.5 1993; Voldsgaard et al., 1994) did not show any evidence of
growth retardation at the gestational ages of 18±20 weeks.vs 55 days; Adolph, 1970), the human newborn is much
larger because of a signi®cantly longer period of intrauterine We have shown that mouse embryos lacking IR exhibit
a small degree of growth retardation detectable only duringlife (280 vs 19 days). In addition to this difference in growth
pattern between these two species, there is neither strict the last gestational day by statistical analysis of embryonic
weights, in contrast to the severe IUGR of human fetusescorrespondence in the order of appearance of equivalent
stages of various embryonic structures nor simple propor- due to insulin inaction. Based on the comparisons described
above, a plausible explanation that we propose for this spe-tionality in the pace of development. In fact, when the ages
of developmental equivalency are compared between mouse cies-difference is a disparity in developmental timing be-
tween humans and mice. From the point of view of thisand human embryos, they cannot be correlated with the
percentage of elapsed gestation time (Otis and Brent, 1954). hypothesis, elimination of insulin action cannot have sig-
ni®cant detrimental consequences for the mouse embryo,This is re¯ected in the degree of maturity that the embryo
has attained at the time of birth. In this regard, mice are since maturation of this hormonal system seems to occur
just prior to birth. In contrast, insulin is apparently involvedborn essentially in an ``embryonic'' state (lack of fur, low
body lipid content, fused eyelids, etc.), while the human in human fetal development during the entire last trimester
of pregnancy. Thus, in the absence of insulin action, a sig-newborns are relatively more mature.
The development and maturation of the insulin system ni®cant amount of time is made available for harmful ef-
fects to occur in utero, which result in the manifestationalso differs between mice and humans, if birth is used as a
reference time point. In the mouse embryo, insulin-produc- of a fully blown growth-de®ciency phenotype in the human
newborn.ing cells in the developing pancreas appear ®rst at e10.5±
e11.5, but they are very few until e13.5 (a few hundred),
increasing 20-fold in number between e13.5 and e15.5, with
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